Recombinant Antibody Production Service

Recombinant antibody production makes it possible to prepare humanized antibodies and human antibodies and is a key technology for the industrialization of monoclonal antibody drugs. Recombinant antibodies are widely used in immunodiagnostics, therapeutic antibodies, and other fields. Gxene Biotech has a well-established recombinant antibody expression and production platform and rich experience in recombinant protein and recombinant antibody expression. Based on phage display technology, we can provide customers with high-quality recombinant antibody preparation and screening services. At the same time, combined with a large-scale recombinant protein fermentation platform, we can produce monoclonal antibodies for customers, including single-chain antibodies (scFv), single-domain antibodies, humanized antibodies, and Fc chimeric antibodies.


Figure 1 Phage display combined with mammalian expression of humanized rabbit IgG

 

Gxene Biotech has multiple recombinant antibody expression systems available for selection. We have four major expression platforms: recombinant protein prokaryotic expression system, recombinant protein yeast expression system, recombinant protein insect expression system, and recombinant protein mammalian cell expression system. According to customer needs, we will adopt different expression systems and strategies.

At the same time, to obtain recombinant antibodies with high affinity and high specificity, we use a complementary strategy combining antibody phage display technology with the above four expression systems to complete antibody preparation services. In the specific experimental process, we use PCR technology to clone and splice the hypervariable region genes of the target antibody heavy chain, namely the CDR regions, into M13 or T7 phagemid vectors to form a heavy-chain CDR region phage display library (the light chain is in secreted form and binds in vitro to the complementary heavy chain to form a complete CDR region). Through antigen gradient panning, the CDR genes of screened high-affinity antibodies are subcloned into different host expression plasmid vectors, thereby achieving high-yield expression of recombinant antibodies.

With the company's GMP/GLP fermentation platform, we can provide customers with recombinant monoclonal antibody expression and preparation services at levels up to 5 g/L. At the same time, the company's large-scale recombinant protein and antibody preparation services include 5 L, 10 L, 30 L, 80 L, 130 L, and 250 L (tandem fermentation can be used to obtain larger fermentation scales).

 

Service Advantages:

 

–Detailed experimental design and justification: including rare codon analysis, protein hydrophilicity analysis, predictive analysis of transmembrane domains, selection of expression systems, degree of antibody modification, etc.

–Various forms of fusion antibody expression: Myc, His, and Flag tag fusion expression, isotope-labeled expression

–Recombinant antibody preparation from diverse species: including human, mouse, rabbit, goat, dog, camel, alpaca, bovine, etc.

–Protein modification control: control of the extent of glycosylation and phosphorylation modifications

–Multiple expression modes: stable expression and transient expression

–Low endotoxin level: LAL assay <0.1 EU/µg

–Complete GMP documentation support system, ensuring that all materials, reagents, and preparation information for your products are traceable

 

Service Workflow:

 

Advantages of Recombinant Antibodies:

 

—Because the gene sequence of recombinant monoclonal antibodies is determined, the prepared antibodies have small batch-to-batch differences and good reproducibility, reducing costs;

—Recombinant antibodies enable large-scale antibody preparation without the use of animals;

—Antibody engineering modification is possible: recombinant antibodies can be recombinantly modified, such as antibody fragment expression, chimeric antibodies, antibody humanization, etc.

📧
🔗
💬
公众号二维码 Scan with WeChat to follow us.
⬆
×

Online Inquiry